TGTX icon

TG Therapeutics

244 hedge funds and large institutions have $2.19B invested in TG Therapeutics in 2023 Q2 according to their latest regulatory filings, with 61 funds opening new positions, 73 increasing their positions, 72 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding

Funds holding:

1% more repeat investments, than reductions

Existing positions increased: 73 | Existing positions reduced: 72

5.65% less ownership

Funds ownership: 64.81%59.17% (-5.6%)

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

Holders
244
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$144M
Puts
$97.6M
Net Calls
Net Calls Change

Top Buyers

1 +$40.4M
2 +$26.5M
3 +$22.3M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$18.4M
5
Man Group
Man Group
United Kingdom
+$17.1M
Name Holding Trade Value Shares
Change
Change in
Stake
76
$3.25M
77
$3.22M
78
$3.06M
79
$2.84M
80
$2.66M
81
$2.57M
82
$2.48M
83
$2.38M
84
$2.28M
85
$2.26M
86
$2.14M
87
$2.1M
88
$2.02M
89
$1.92M
90
$1.9M
91
$1.86M
92
$1.8M
93
$1.8M
94
$1.78M
95
$1.78M
96
$1.75M
97
$1.73M
98
$1.69M
99
$1.67M
100
$1.64M